Morgan Stanley upgraded Globe Life (GL) to Overweight from Equal Weight with a price target of $166, up from $135. The firm believes the end of SEC and DOJ investigations should remove significant uncertainty on the the shares. With the investigative headwinds removed, investor focus should shift back to Globe Life’s fundamentals and “steady” earnings growth, the analyst tells investors in a research note. Morgan Stanley sees a path to multiple expansion for the shares.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GL:
- Globe Life price target raised to $149 from $114 at BMO Capital
- Positive Regulatory Outcomes Reinforce Buy Rating for Globe Life
- Globe Life price target raised to $160 from $155 at Keefe Bruyette
- Early notable gainers among liquid option names on July 29th
- Globe Life Cleared by DOJ and SEC Investigations